What development phase is Bambudil in?

Bambudil is FDA-approved (marketed).

What is the generic name of Bambudil?

BAMBUTEROL is the generic (nonproprietary) name of Bambudil.

Last reviewed 2026-04-20 · How we verify

Bambudil (BAMBUTEROL)

FDA-approved active Small molecule Quality 19/100

At a glance

Generic name	BAMBUTEROL
Drug class	bambuterol
Target	Acetylcholinesterase, Beta-2 adrenergic receptor, Cholinesterase
Modality	Small molecule
Therapeutic area	Respiratory
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Effect of Home-base Exercise With Conical-PEP Device on Physical Performance and Quality of Life in COPD (NA)
Effects and Safety of Different Dose of Bambuterol on Chinese COPD Patients (PHASE4)
The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma (PHASE4)
The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Bambudil CI brief — competitive landscape report
Bambudil updates RSS · CI watch RSS